| Baldwin, D. R., Duffy, S. W., Wald, N. J., Page, R., Hansell, D. M., & Field, J. K. UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer, Thorax, vol. 66, no. 4, pp. 308-313. |
| Davenport, R., Manson, J., De'Ath, H., Platton, S., Coates, A., Allard, S., Hart, D., Pearse, R., Pasi, K. J., MacCallum, P., Stanworth, S., & Brohi, K. Point of care diagnostics for the rapid identification of acute traumatic coagulopathy and prediction of massive trauma haemorrhage, British Journal of Surgery, vol. 98, p. 7. |
| Field, J. K., Duffy, S., Baldwin, D., Brain, K., Eisen, T., Hands, C. J. D., Kerr, K. M., Page, R., Parmar, M., Wald, N., Weller, D., Whynes, D., Williamson, P., & Hansell, D. United Kingdom Lung Cancer Screening (Ukls) Trial, Journal of Thoracic Oncology, vol. 6, no. 6, p. S1382-S1383. |
| He, F. J. & Macgregor, G. A. Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials, Lancet, vol. 378, no. 9789, pp. 380-382. |
| He, F. J., Jenner, K. H., Farrand, C. E., & Macgregor, G. A. World Salt Awareness Week, J.Clin.Hypertens.(Greenwich.), vol. 13, no. 3, pp. 141-145. |
| Johnson, S., Hollis, C., Hennessy, E., Kochhar, P., Wolke, D., & Marlow, N. Screening for autism in preterm children: diagnostic utility of the Social Communication Questionnaire, Archives of Disease in Childhood, vol. 96, no. 1, pp. 73-77. |
| Johnson, S., Wolke, D., Hennessy, E., & Marlow, N. Educational Outcomes in Extremely Preterm Children: Neuropsychological Correlates and Predictors of Attainment, Developmental Neuropsychology, vol. 36, no. 1, pp. 74-95. |
| Lum, S., Kirkby, J., Welsh, L., Marlow, N., Hennessy, E., & Stocks, J. Nature and severity of lung function abnormalities in extremely pre-term children at 11 years of age, European Respiratory Journal, vol. 37, no. 5, pp. 1199-1207. |
| Marrero N.M., He, F. J., & Macgregor, G. A. "Current experience and future perspectives for worldwide reduction of dietary salt intake," in Nutritional and Metabolic Bases of Cardiovascular Disease, Mancini M. et al., eds., Wiley-Blackwell, pp. 353-364. |
| McEniery, C. M., Bolton, C. E., Fawke, J., Hennessy, E., Stocks, J., Wilkinson, I. B., Cockcroft, J. R., & Marlow, N. Cardiovascular consequences of extreme prematurity: the EPICure study, Journal of Hypertension, vol. 29, no. 7, pp. 1367-1373. |
| Millar, M., Zhou, W., Skinner, R., Pizer, B., Hennessy, E., Wilks, M., & Gilbert, R. E. Accuracy of bacterial DNA testing for central venous catheter-associated bloodstream infection in children with cancer, Health Technology Assessment, vol. 15, no. 7, pp. 1-114. |
| Morris, J. K., Wald, D. S., & Wald, N. J. The evaluation of cascade testing for familial hypercholesterolemia, Am.J.Med.Genet.A, vol. 158A, no. 1, pp. 78-84. |
| Provan A., Newland A.C., & MacCallum P.K. "Acquired disorders affecting megakaryocytes and platelets," in Blood and Bone Marrow Pathology, 2nd edn, Porwit A., McCullough J., & Erber W., eds., Elsevier, pp. 523-545. |
| Simmonds, M. & Wald, N. SNPs and coronary heart disease, Lancet, vol. 377, no. 9763, pp. 379-380. |
| Simmonds, M. C. & Wald, N. Screening for cardiovascular disease: concerns with a Norwegian proposal, J.Med.Screen., vol. 18, no. 4, pp. 165-166. |
| Uhry, Z., Hedelin, G., Colonna, M., & Duffy, S. Reply to: Lost opportunity to usefully examine French breast cancer screening mortality, Cancer Epidemiology, vol. 35, no. 3, pp. 307-308. |
| Uhry, Z., Hedelin, G., Colonna, M., Asselain, B., Arveux, P., Exbrayat, C., Guldenfelds, C., Soler-Michel, P., Molinie, F., Tretarre, B., Rogel, A., Courtial, I., Danzon, A., Guizard, A. V., Ancelle-Park, R., Eilstein, D., & Duffy, S. Modelling the effect of breast cancer screening on related mortality using French data, Cancer Epidemiology, vol. 35, no. 3, pp. 235-242. |
| Wald, D. S. & Wald, N. J. The Polypill in the prevention of cardiovascular disease, Prev.Med., vol. 52, no. 1, pp. 16-17. |
| Wald, D. S., Kasturiratne, A., Godoy, A., Ma, L., Bestwick, J. P., Brewer, N., & Wald, N. J. Child-Parent Screening for Familial Hypercholesterolemia, Journal of Pediatrics, vol. 159, no. 5, pp. 865-867. |
| Wald, D. S., Morris, J. K., & Wald, N. J. Reconciling the evidence on serum homocysteine and ischaemic heart disease: a meta-analysis, PLoS.One., vol. 6, no. 2, p. e16473. |
| Wald, D. S., Kasturiratne, A., & Simmonds, M. Serum homocysteine and dementia: Meta-analysis of eight cohort studies including 8669 participants, Alzheimers & Dementia, vol. 7, no. 4, pp. 412-417. |
| Wald, N. Unified prenatal screening for Down's syndrome and pre-eclampsia, Clinical Biochemistry, vol. 44, no. 7, p. 455. |
| Wald, N. "Introduction," in The Future of Prevention in Cardiovascular Disease, N. Wald & Misselbrook D, eds., Royal Society of Medicine Press, London, p. xi. |
| Wald, N. "Medicines in prevention," in The Future of Prevention on Cardiovascular Disease, N. Wald & Misselbrook D, eds., Royal Society of Medicine Press, London, pp. 1-15. |
| Wald, N. "Nutrition in prevention," in The Future of Prevention in Cardiovascular Disease, N. Wald & Misselbrook D, eds., Royal Society of Medicine Press, London, pp. 42-55. |
| Wald, N. J. Genetic testing, J.Med.Screen., vol. 18, no. 2, p. 55. |
| Wald, N. J., Morris, J. K., & Law, M. R. Aspirin in the prevention of cancer, Lancet, vol. 377, no. 9778, pp. 1649-2. |
| Wald, N. J. & Oppenheimer, P. Discounting the value of life, J.Med.Screen., vol. 18, no. 1, p. 1. |
| Wald, N. J. Community Corner: Opening the Pandora's box of prenatal genetic testing, Nat.Med., vol. 17, no. 3, pp. 250-251. |
| Wald, N. J. & Morris, J. K. Assessing risk factors as potential screening tests: a simple assessment tool, Arch.Intern.Med., vol. 171, no. 4, pp. 286-291. |
| Wald, N. J., Simmonds, M., & Morris, J. K. Screening for future cardiovascular disease using age alone compared with multiple risk factors and age, PLoS.One., vol. 6, no. 5, p. e18742. |
|
